Compare · INSP vs MDLN
INSP vs MDLN
Side-by-side comparison of Inspire Medical Systems Inc. (INSP) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INSP and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 23.7x INSP ($2.03B).
- Over the past year, INSP is down 12.1% and MDLN is down 11.8% - MDLN leads by 0.4 points.
- INSP has been more active in the news (8 items in the past 4 weeks vs 7 for MDLN).
- Both have 25 recent analyst ratings on file.
- Company
- Inspire Medical Systems Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $2.03B
- $48.08B
- 1M return
- -5.82%
- +11.97%
- 1Y return
- -12.13%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- 2025
- News (4w)
- 8
- 7
- Recent ratings
- 25
- 25
Inspire Medical Systems Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest INSP
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
- Barclays initiated coverage on Inspire Medical Systems with a new price target
- Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
- Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
- Officer Kelly Jason P was granted 6,350 shares, increasing direct ownership by 33% to 25,335 units (SEC Form 4)
- Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M